US 8129399
Aminopyrimidines useful as kinase inhibitors
granted A61PA61P19/08A61P25/28
Quick answer
US patent 8129399 (Aminopyrimidines useful as kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P19/08, A61P25/28, A61P27/14, A61P29/00